Open AccessUterine artery embolization – clinical problems
Author(s) -
Ewa Woźniakowska,
Paweł Milart,
Tomasz Paszkowski,
Tomasz Palacz,
Sławomir Woźniak,
Wojciech Wrona,
Piotr Szkodziak,
Maciej Paszkowski,
Piotr Czuczwar
Publication year - 2013
Publication title -
ginekologia polska
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 21
eISSN - 2543-6767
pISSN - 0017-0011
DOI - 10.17772/gp/1679
Subject(s) - medicine , uterine artery embolization , amenorrhea , premature ovarian failure , menopause , fibroma , complication , pregnancy , embolization , uterus , surgery , obstetrics , gynecology , anatomy , biology , genetics
The aim of the study was to present clinical issues concerning uterine artery embolization (UAE) in women with uterine fibromas. In order to ensure high clinical efficiency of UAE and prevent subsequent complications, it is necessary to carefully select patients eligible for the procedure. Patients with intramural fibromas, who do not plan to conceive, are the best candidates for the procedure. Fibroma necrosis, with following infection, and premature ovarian failure remain to be the most common complications after UAE. UAE may cause amenorrhea and increase FSH levels, what is typical for menopause. Thus, it may be responsible for problems with conception as well as optimal development of a pregnancy. It may also cause premature, iatrogenic menopause. This complication significantly more frequently occurs in women over the age of 45 as compared to younger patients. UAE is considered as an alternative therapeutic procedure, available to women who do not desire the surgery or wish to preserve the uterus. Patients subject to this procedure should be informed about the possible side effects.